B
BioVie D
D
BIVI
1.48000
USD
-0.15
(-9.20%)
مغلق
حجم التداول
7,346
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
27,308,932
المقالات
العنوان: BioVie Inc
القطاع: Healthcare
الصناعة: Biotechnology
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.